Association of the Sialylation of Antibodies Specific to the HCV E2 Envelope Glycoprotein with Hepatic Fibrosis Progression and Antiviral Therapy Efficacy

<div>HCV E2 glycoprotein-specific antibody sialylation pattern in patients with F0 and F4 fibrosis stage by HCV genotype.</div>

Disease Markers

tab2

Table 2

Table 2: Association of the Sialylation of Antibodies Specific to the HCV E2 Envelope Glycoprotein with Hepatic Fibrosis Progression and Antiviral Therapy Efficacy 

Table 2 | Association of the Sialylation of Antibodies Specific to the HCV E2 Envelope Glycoprotein with Hepatic Fibrosis Progression and Antiviral Therapy Efficacy 